This study is a regulatory post marketing surveillance in Japan, and it is a local
prospective and observational study of patients who have received YAZ for dysmenorrhea. The
objective of this study is to assess safety and efficacy of using YAZ in clinical practice. A
total 3,000 patients will be recruited and followed 3 years since starting YAZ
administration.